基本信息
浏览量:1725
职业迁徙
个人简介
My main research has focused on molecular, genetic, and nutritional epidemiology of cancer and other chronic diseases. My current research is supported by several NIH grants, including an NCI MERIT award. I have authored or co-authored more than 750 publications. Over the past seven years, I have directed two large genetic research consortia in East Asians that have identified more than 30 novel susceptibility loci/genetic variants for breast and colorectal cancers. I am the PI for the Shanghai Women's Health Study including approximately 75,000 study participants. I am a key founding co-investigator of the Shanghai Men's Health Study and the Southern Community Cohort Study (SCCS) and currently serve as a joint PI for the SCCS. I also initiated the Nashville Breast Health Study and the Tennessee Colorectal Polyp Study, in which more than 12,000 cases and controls were recruited.
研究兴趣
论文共 1895 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer chemotherapy and pharmacology (2024)
Journal of the National Medical Associationno. 2 Pt 1 (2024): 189-201
Batel Blechter,Chao Agnes Hsiung,Keitaro Matsuo, Kouya Shiraishi, Kevin Wang,Haoyu Zhang,Wei Jie Seow,Jianxin Shi,Nilanjan Chatterjee,Jason Y.Y. Wong,Juncheng Dai, H. Dean Hosgood,
Cancer Researchno. 6_Supplement (2024): 6149-6149
British Journal of Cancerpp.1-9, (2024)
Frontiers in Psychiatry (2024): 1331780-1331780
Jungyoon Choi,Kyong Hwa Park,Yeul Hong Kim, Jason K Sa,Hwa Jung Sung,Yu-Wei Chen,Zhishan Chen, Chao Li,Wanqing Wen,Qingrun Zhang,Xiao-Ou Shu,Wei Zheng,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Cancer Chemotherapy and Pharmacology (2024)
Cancer Chemotherapy and Pharmacologypp.1-12, (2024)
Cancer Researchno. 6_Supplement (2024): 2214-2214
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn